Supplements and Nutraceuticals
“First, do no harm. Second, be honest about what we don’t know.” This chapter reviews supplements and nutraceuticals commonly used in ME/CFS. We emphasize accessible, over-the-counter options that patients can try without prescription, while being honest about the limited evidence base. Most supplements have not been rigorously tested in ME/CFS-specific trials; recommendations are based on mechanism, related-condition evidence, and patient-reported outcomes.
Very few supplements have been tested in randomized controlled trials specifically for ME/CFS. Most evidence comes from: (1) mechanistic plausibility based on documented ME/CFS abnormalities, (2) trials in related conditions (fibromyalgia, Long COVID, chronic fatigue), (3) small open-label studies, and (4) patient surveys. We note the evidence level for each supplement. “Widely used” does not mean “proven effective.”
Despite widespread use and biological plausibility, the supplement recommendations in this chapter face a fundamental evidence gap:
- Fewer than five supplements discussed here have been tested in randomized placebo-controlled trials specifically in ME/CFS—notably NADH (Forsyth et al. 1999) and CoQ10+NADH (Castro-Marrero et al. 2021). Acetyl-L-carnitine has been studied in a randomized (open-label) ME/CFS trial (Vermeulen and Scholte 2004) but without a placebo arm. Most evidence for other supplements derives from mechanistic reasoning, related-condition trials, or patient surveys with inherent reporting bias.
- The observation that “widely used” supplements dominate patient community recommendations does not constitute efficacy evidence; popular adoption may reflect hope, accessibility, and social transmission rather than therapeutic benefit.
- Combination protocols (e.g., CoQ10 + L-carnitine + D-ribose) are recommended based on complementary biochemical rationale, but potential interactions, optimal ratios, and combined efficacy have not been studied.
- Supplement quality, bioavailability, and dose-response relationships vary substantially between brands and formulations—factors not addressed by the general dosing ranges provided.
For patients: start with the foundational electrolytes and hydration section (Foundational Supplements: Electrolytes and Hydration) — often the single most impactful step — then the mitochondrial and energy-support section (Mitochondrial and Energy Support) for the best-evidenced supplements; read the HIT-safe electrolyte notes if you have mast-cell or histamine sensitivity.
For caregivers: use the electrolytes section to prepare a safe DIY oral-rehydration solution, and the energy-support section to help the patient budget supplement costs against the evidence.
For clinicians: read the combination guide within Mitochondrial and Energy Support for evidence-based pairing (e.g., CoQ10 + NADH) and the drug-interaction warnings; note each supplement’s evidence level before recommending.
For researchers: read the limitation block first — fewer than five supplements have ME/CFS-specific RCTs; the chapter maps the mechanism-based reasoning and related-condition evidence that needs ME/CFS-specific validation.
1 Contents
- Foundational Supplements: Electrolytes and Hydration
- Mitochondrial and Energy Support
- Antioxidant and Anti-inflammatory Supplements
- B Vitamins
- Vitamin D
- Amino Acids
- Practical Supplement Protocols
- Additional Supplements
- Probiotics and Gut Health
- Supplement Quality and Safety
- Immunomodulatory Supplements for B Cell and Autoantibody Regulation
- Connective Tissue Support Supplements
- Thermoregulatory Support Supplements
- What the Response Tells Us About Select Supplements
- Conclusion
- Brain Clearance Architecture: Supplement Proposals